Ann: DMX-700 Study Shows Significant 80% Reduction in Lung Injury, page-3

Great news for DXB.

COPD is a terrible illness, affecting a great many people. There is no cure, and current treatments have very limited impact beyond symptomatic relief and a limited slowing of disease progression.

So this statement leaps out at me: "blocking the known targets of COPD with DMX-700 at the same time results in a statistically significant decrease in lung injury that leads to fibrosis, or scarring. These new results confirm the efficacy of DMX-700 in an industry-standard preclinical COPD model reducing lung injury by 80%."

If they can do that in humans, without major side effects, DMX-700 will be huge.

Cheers

Dave